# Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PD

> **NCT01655004** · NA · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 110 (estimated)

## Conditions studied

- Breast Carcinoma

## Interventions

- **DRUG:** Exemestane

## Key facts

- **NCT ID:** NCT01655004
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2017-06
- **Final completion:** 2018-08
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2016-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01655004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01655004, "Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01655004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*